This laboratory study extracted beta-glucan from the Candida albicans cell wall and exposed parental and sphere-forming LL/2 lung-carcinoma cells to a range of concentrations for 24 to 72 hours. Cell viability was assessed with an MTT assay, and expression of Sox2, Oct4, C-myc, and Nanog was measured. The authors reported cytotoxic effects at selected concentrations and lower Oct4 and Sox2 expression. These are in-vitro findings and require confirmation in additional laboratory and animal studies before any clinical interpretation.
This study investigated the immunostimulatory effects of Candida cell wall β-glucan, examining how this specific β-glucan source affects immune cell function and treatment response in fungal infection models.
Candida-derived cell wall β-glucan demonstrated significant immunostimulatory effects, activating innate immune cells through Dectin-1 receptor engagement. The research showed β-glucan from pathogenic Candida can paradoxically be harnessed to enhance anti-fungal immunity when presented in purified form.
Cross-species comparison of fungal β-glucan immunostimulatory effects supports the universal nature of β-1,3-glucan receptor recognition. AP-glucan from Aureobasidium pullulans engages the same Dectin-1 pathway, suggesting comparable immune activation capacity.
AI-generated summary for accessibility. Always refer to the original paper.
Sadeghi, Fatemeh; Peymaeei, Fatemeh; Falahati, Mehraban; Safari, Elaheh; Farahyar, Shirin; Roudbar Mohammadi, Shahla; Roudbary, Maryam. The effect of Candida cell wall beta-glucan on treatment-resistant LL/2 cancer cell line: in vitro evaluation. Molecular Biology Reports. 2020. DOI: 10.1007/s11033-020-05459-7. PMID: 32323263.
For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.